Lucid Diagnostics, Inc. (LUCD)
0.4077
+0.01
(+2.18%)
USD |
NASDAQ |
Nov 18, 16:00
0.399
-0.01
(-2.13%)
After-Hours: 20:00
Lucid Diagnostics Enterprise Value : 78.35M for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 78.35M |
| November 17, 2026 | 76.69M |
| November 16, 2026 | 76.46M |
| November 13, 2026 | 86.26M |
| November 12, 2026 | 80.00M |
| November 11, 2026 | 73.33M |
| November 10, 2026 | 76.88M |
| November 09, 2026 | 80.23M |
| November 06, 2026 | 76.50M |
| November 05, 2026 | 74.99M |
| November 04, 2026 | 85.50M |
| November 03, 2026 | 78.60M |
| November 02, 2026 | 78.09M |
| October 30, 2026 | 77.80M |
| October 29, 2026 | 83.05M |
| October 28, 2026 | 79.10M |
| October 27, 2026 | 84.16M |
| October 26, 2026 | 96.11M |
| October 23, 2026 | 78.98M |
| October 22, 2026 | 63.08M |
| October 21, 2026 | 64.16M |
| October 20, 2026 | 67.70M |
| October 19, 2026 | 72.57M |
| October 16, 2026 | 91.78M |
| October 15, 2026 | 99.82M |
| Date | Value |
|---|---|
| October 14, 2026 | 104.21M |
| October 13, 2026 | 116.22M |
| October 12, 2026 | 114.58M |
| October 09, 2026 | 122.34M |
| October 08, 2026 | 124.65M |
| October 07, 2026 | 119.57M |
| October 06, 2026 | 115.08M |
| October 05, 2026 | 113.80M |
| October 02, 2026 | 120.29M |
| October 01, 2026 | 121.72M |
| September 30, 2026 | 143.92M |
| September 29, 2026 | 145.83M |
| September 28, 2026 | 145.20M |
| September 25, 2026 | 149.07M |
| September 24, 2026 | 151.36M |
| September 23, 2026 | 151.53M |
| September 22, 2026 | 161.77M |
| September 21, 2026 | 152.71M |
| September 18, 2026 | 141.38M |
| September 17, 2026 | 140.37M |
| September 16, 2026 | 151.05M |
| September 15, 2026 | 142.89M |
| September 14, 2026 | 140.79M |
| September 11, 2026 | 140.85M |
| September 10, 2026 | 144.89M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| PAVmed, Inc. | 3.170M |
| Stereotaxis, Inc. | 104.50M |
| Glaukos Corp. | 13.56B |
| CVRx, Inc. | 17.84M |
| Hyperfine, Inc. | 33.30M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.677M |
| Revenue (Quarterly) | 1.203M |
| Total Expenses (Quarterly) | 7.88M |
| EPS Diluted (Quarterly) | -0.035 |
| Gross Profit Margin (Quarterly) | -35.41% |
| Profit Margin (Quarterly) | -555.0% |
| Earnings Yield | -100.1% |
| Normalized Earnings Yield | -100.69 |